DS
LIMNW

David Shaw’s Liminatus Pharma Warrants LIMNW Stock Holding History

David Shaw’s Portfolio LIMNW Stock Details LIMNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.93K Hold
83,353
– – ﹤0.01% 4814
2026
Q1 		$3.33K Hold
83,353
– – ﹤0.01% 4450
2025
Q4 		$2.92K Hold
83,353
– – ﹤0.01% 4539
2025
Q3 		$10K Hold
83,353
– – ﹤0.01% 4465
2025
Q2 		$20.2K Buy
+83,353
New +$16.4K ﹤0.01% 4223

Other funds holding LIMNW

AC
Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return
LA
Linden Advisors New York $19.3B AUM 1.47% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
MCM
Moore Capital Management New York $6.74B AUM 45.87% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
ACA
Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $665M AUM 95.48% 1-Year Est. Return

David Shaw's LIMNW Position: Q2 2026 in Review

David Shaw held its Liminatus Pharma Warrants (LIMNW) position steady in Q2 2026 at 83,353 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #4814.

David Shaw first reported a position in LIMNW in Q2 2025 and has held it in 5 quarters since. The position peaked at $20.2K in Q2 2025. 22 funds tracked by Wall St. Rank hold LIMNW as of Q2 2026.

  • David Shaw held 83,353 shares of Liminatus Pharma Warrants worth $2.93K as of Q2 2026.
  • David Shaw left its Liminatus Pharma Warrants share count unchanged in Q2 2026.
  • Liminatus Pharma Warrants made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #4814 holding.
  • David Shaw first reported a position in Liminatus Pharma Warrants in Q2 2025 and has held it in 5 quarters since.
  • David Shaw's Liminatus Pharma Warrants position peaked at $20.2K in Q2 2025.
  • 22 funds tracked by Wall St. Rank held Liminatus Pharma Warrants as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.